Eye Diseases, Hereditary
Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.
Subtype terms (23)
More specific conditions that are subtypes of Eye Diseases, Hereditary in the MeSH hierarchy.
- Aicardi Syndrome
5 drugs approved
- Albinism
6 drugs (4 approved, 2 experimental)
- Aniridia
1 drug experimental
- Choroideremia
9 drugs (2 approved, 7 experimental)
- Coloboma
- Cone Dystrophy
- Cone-Rod Dystrophies
3 drugs experimental
- Corneal Dystrophies, Hereditary
3 drugs (2 approved, 1 experimental)
- Duane Retraction Syndrome
- Familial Exudative Vitreoretinopathies
1 drug approved
- Graves Ophthalmopathy
69 drugs (42 approved, 27 experimental)
- Gyrate Atrophy
- Leber Congenital Amaurosis
15 drugs (6 approved, 9 experimental)
- Optic Atrophies, Hereditary
1 drug experimental
- Optic Nerve Hypoplasia
2 drugs (1 approved, 1 experimental)
- Retinal Degeneration
31 drugs (9 approved, 22 experimental)
- Retinal Dysplasia
- Retinitis Pigmentosa
77 drugs (21 approved, 56 experimental)
- Retinoblastoma
57 drugs (34 approved, 23 experimental)
- Stargardt Disease
19 drugs (5 approved, 14 experimental)
- Vitelliform Macular Dystrophy
2 drugs (1 approved, 1 experimental)
- Walker-Warburg Syndrome
- Weill-Marchesani Syndrome
Drugs by status
Phase 4 trials (10)
Phase 3 trials (3)
Phase 1 trials (7)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (1)